Conservative Treatment of Ankle Osteoarthritis

No Thumbnail Available

Date

2021-10-01

Authors

Tejero, Sergio
Prada-Chamorro, Estefania
Gonzalez-Martin, David
Garcia-Guirao, Antonio
Galhoum, Ahmed
Valderrabano, Victor
Herrera-Perez, Mario

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Mdpi
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Despite the disabling nature of ankle osteoarthritis (OA), there is poor scientific evidence for a conservative treatment compared to the hip and knee OA. In this regard, most of the treatment options in use are not based on clinical studies of the ankle, and they are extracted from evidence obtained from clinical studies of other lower limb joints. However, this does not seem to be a good idea, since the aetiology of ankle OA is quite different from that of the hip or knee. Nonpharmacological and pharmacological treatments such as nonsteroidal anti-inflammatory drugs, hyaluronic acid, corticosteroid, platelet-rich plasma injection and mesenchymal stem cells injections have been reported. However, further research is required in this field to obtain a specific clinical practice guideline for the conservative treatment of ankle OA.

Description

MeSH Terms

DeCS Terms

CIE Terms

Keywords

conservative treatment ankle osteoarthritis, viscosupplementation, platelet-rich plasma, mesenchymal stem cells, biologics, Platelet-rich plasma, Intraarticular injection, Follow-up, Hyaluronate, Arthritis, Efficacy, Safety, Foot, Knee

Citation